NCT01789619View on ClinicalTrials.gov

Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients

CompletedOBSERVATIONAL
Enrollment

9

Participants

Timeline

Start Date

October 31, 2012

Primary Completion Date

January 31, 2014

Study Completion Date

January 31, 2014

Conditions
Atopic Dermatitis
Interventions
DRUG

Extended release tacrolimus (Advagraf®)

Trial Locations (1)

3584CX

University Medical Center Utrecht, Utrecht

All Listed Sponsors
lead

UMC Utrecht

OTHER

NCT01789619 - Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients | Biotech Hunter | Biotech Hunter